SiteOne Gets $100M To Advance Non-Opioid Pain Treatments
By Jade Martinez-Pogue · December 18, 2024, 12:01 PM EST
SiteOne Therapeutics Inc., a biopharmaceutical company focusing on pain treatment, on Wednesday announced that it clinched a Series C funding round after securing $100 million from investors....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login